Categories

CEO Mark Capone looks at the pioneering role Myriad is playing a as we enter the golden era of molecular diagnostics…

Continue Reading

CEO Mark Capone talks about our mission, which is to answer patients’ four most pressing questions in six medical specialties.

Continue Reading


CEO Mark Capone describes the Myriad Vision and what it means to us. “We want to be the trusted advisor transforming…

Continue Reading

Myriadians are passionate about saving and improving the lives of patients worldwide with our breakthrough molecular diagnostic tests. That commitment extends…

Continue Reading

CEO Mark Capone talks about why patients and physicians choose Myriad when decisions matter most. “We recognize that patients are going…

Continue Reading

Myriad has changed a lot over the past 20 years. We’ve gone from being a single product company in just the…

Continue Reading

At Myriad, corporate responsibility plays an important role in our approach to discovering and delivering valuable, transformative diagnostic tests across all…

Continue Reading

On August 13, 2015, Medicare approved coverage of the Prolaris® test for men diagnosed with low-risk and very low-risk prostate cancer.…

Continue Reading